A unique case of very low-dose subcutaneous ketamine use: Maintenance option of ketamine for treatment-resistant depression

被引：1
作者：
Can, Adem T. T. [1 ]
Hermens, Daniel F. F. [1 ]
Lagopoulos, Jim [1 ]
机构：
[1] Univ Sunshine Coast, Thompson Inst, Birtinya, QLD, Australia
来源：
CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期
关键词：
depression; ketamine; MADRS; NMDA; suicidality; treatment-resistant; TRIAL; DISORDER; STRESS;
D O I：
10.1002/ccr3.6675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Numerous studies have demonstrated that low-dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment-resistant depression. The following case report describes the use of a very low-dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment-resistant depression using a retrospective chart review.
引用
收藏
页数：6
相关论文
共 50 条
[41]   Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain [J].
Lopez-Diaz, Alvaro ;
Luis Fernandez-Gonzalez, Jose ;
Evaristo Lujan-Jimenez, Jose ;
Galiano-Rus, Sara ;
Gutierrez-Rojas, Luis .
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (04) :137-140
[42]   Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammation [J].
Chen, Mu-Hong ;
Su, Tung-Ping ;
Lin, Wei-Chen ;
Li, Cheng-Ta ;
Wu, Hui-Ju ;
Tsai, Shih-Jen ;
Bai, Ya-Mei ;
Mao, Wei-Chung ;
Tu, Pei-Chi .
PHARMACOPSYCHIATRY, 2024,
[43]   Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression [J].
aan het Rot, Marije ;
Collins, Katherine A. ;
Murrough, James W. ;
Perez, Andrew M. ;
Reich, David L. ;
Charney, Dennis S. ;
Mathew, Sanjay J. .
BIOLOGICAL PSYCHIATRY, 2010, 67 (02) :139-145
[44]   Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression [J].
Hossein, Shabnam ;
Rengasamy, Manivel ;
Uzamere, Aiyedun ;
Spotts, Crystal ;
Howland, Robert H. ;
Wallace, Meredith L. ;
Mathew, Sanjay J. ;
Price, Rebecca B. .
BRITISH JOURNAL OF PSYCHIATRY, 2025,
[45]   Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study [J].
Chen, Mu -Hong ;
Kao, Chung-Feng ;
Tsai, Shih-Jen ;
Li, Cheng -Ta ;
Lin, Wei-Chen ;
Hong, Chen-Jee ;
Bai, Ya-Mei ;
Tu, Pei -Chi ;
Su, Tung-Ping .
GENOMICS, 2021, 113 (02) :507-514
[46]   Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence [J].
Di Vincenzo, Joshua D. ;
Lipsitz, Orly ;
Rodrigues, Nelson B. ;
Lee, Yena ;
Gill, Hartej ;
Kratiuk, Kevin ;
Subramaniapillai, Mehala ;
Mansur, Rodrigo ;
McIntyre, Roger S. ;
Rosenblat, Joshua D. .
JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 143 :209-214
[47]   ROLE OF KLOTHO ON ANTIDEPRESSANT AND ANTISUICIDAL EFFECTS OF LOW-DOSE KETAMINE INFUSION AMONG PATIENTS WITH TREATMENT-RESISTANT DEPRESSION AND SUICIDAL IDEATION [J].
Chen, Mu-Hong ;
Wu, Hui-Ju .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 :I21-I21
[48]   Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review [J].
Ng, Jason ;
Rosenblat, Joshua D. ;
Lui, Leanna M. W. ;
Teopiz, Kayla M. ;
Lee, Yena ;
Lipsitz, Orly ;
Mansur, Rodrigo B. ;
Rodrigues, Nelson B. ;
Nasri, Flora ;
Gill, Hartej ;
Cha, Danielle S. ;
Subramaniapillai, Mehala ;
Ho, Roger C. ;
Cao, Bing ;
McIntyre, Roger S. .
JOURNAL OF AFFECTIVE DISORDERS, 2021, 293 :285-294
[49]   Low-dose subcutaneous ketamine infusion and morphine tolerance [J].
Bell, RF .
PAIN, 1999, 83 (01) :101-103
[50]   Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation [J].
Chen, Mu-Hong ;
Bai, Ya-Mei ;
Wu, Hui-Ju ;
Li, Cheng-Ta ;
Lin, Wei-Chen ;
Tsai, Shih-Jen ;
Su, Tung-Ping ;
Tu, Pei-Chi .
JOURNAL OF AFFECTIVE DISORDERS, 2023, 340 :471-475
12345